Concepedia

Lingquan Kong

LK

25

Publications

797

Citations

16

H-Index

2008

Active since

Affiliations

Chongqing Medical University(Current)

The Affiliated Yongchuan Hospital of Chongqing Medical University

Affiliated Hospital of North Sichuan Medical College

Incyte (United States)

Peking University

Lingquan Kong is an author at Chongqing Medical University specializing in medicine, breast cancer, and diabetes.

ORCID

Top concepts

Publications per year

2008–2024

25

Publications

25

Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy

Xin Li, Zili Liu, Yutuan Wu et al. · Lipids in Health and Disease · 2018 · 139 citations · Full text

Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study

Yuling Chen, Hao Li, Shu Li et al. · BMC Gastroenterology · 2021 · 103 citations · Full text

Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine

Jianbo Huang, Liangbin Jin, Guangyan Ji et al. · BMC Cancer · 2013 · 55 citations · Full text

Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist

Chu‐Biao Xue, Hao Feng, Ganfeng Cao et al. · ACS Medicinal Chemistry Letters · 2011 · 48 citations · Full text

, , +13

Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist

Chu‐Biao Xue, Anlai Wang, Qi Han et al. · ACS Medicinal Chemistry Letters · 2011 · 45 citations · Full text

Rows per page

1–5 of 25